Metropolis Healthcare Ltd Share Price

Overview

Metropolis Healthcare Ltd share price is currently ₹558.02, up by ₹1.47 (0.26%) from its previous closing price of ₹556.55. The share price has declined -1.8% over the past month and gained 5% over the past year. The stock's 52-week low and high are ₹407.56 and ₹601.60, respectively. Metropolis Healthcare Ltd has a market capitalisation of ₹ 11,550.00 Cr. The share price was last updated on 25 Aug 2026, 03:30 PM IST.

Metropolis Healthcare Ltd

METROPOLIS

₹0.00

₹1.47

0.26%

Healthcare

₹0.00(%)1D

Updated: 25 Aug 2026, 03:30:00 pm IST

Market Data

Open Price

₹555.39

Prev. Close

₹556.55

₹553.39

Day Low

₹559.55

Day High

₹407.56

52 Week Low

₹601.60

52 Week High

HealthcareHospital & Healthcare Services

CategoryMid Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

57.35

Sector PE

42.03

PB Ratio

7.70

Sector PB

5.83

EPS

9.73

Dividend Yield

1.15

Today's Volume

150.460 K

5 Day Avg. Volume

328.928 K

PEG Ratio

-0.85

Market Cap.

₹ 11,550.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Actions	Ex-Date	Record-Date
DividendsInterim Dividend of 50% at ₹1/Share	19-May-2026	19-May-2026
Bonus3:1	20-Mar-2026	20-Mar-2026
DividendsInterim Dividend of 200% at ₹4/Share	11-Nov-2025	11-Nov-2025

Mutual Fund Ownership

Mutual Fund Holder	Jun 26 Shares held	Jul 26 Shares held
HDFC Focused Fund - Regular Plan - Growth	68.00 Lac	68.00 Lac no change
HDFC Flexi Cap Fund - Growth	65.00 Lac	65.00 Lac no change
Kotak Small Cap Fund - Growth	63.80 Lac	63.80 Lac no change
Nippon India Small Cap Fund - Growth	45.81 Lac	45.81 Lac no change
Franklin India Small Cap Fund - Growth	43.73 Lac	43.73 Lac no change

Show all holdings

About Metropolis Healthcare Ltd 👋

Metropolis Healthcare Limited is engaged in providing diagnostic services to patients, healthcare providers, and corporates across India and Africa. It has a single operating segment, namely Pathology services. It is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, other pathological and radiological investigations. Its services include Pathology Testing Services, Corporate Wellness, Lab In Hospitals and Clinical Research Services. It serves a diverse customer base, including B2C (Business to Consumer), B2B (Business to Business), and institutional clients. It offers more than 4,000 tests and profiles, including advanced tests for diagnosing cancer, neurological disorders, infectious diseases, and various genetic abnormalities. Its footprint spans 28 states, seven Union Territories.